Search Results

You are looking at 21 - 30 of 1,072 items for :

  • "community" x
  • Refine by Access: All x
Clear All
Full access

HSR24-174: Underserved Patients Find Their Voice Through Newly Formed SCLC Community

Dusty Joy Donaldson and Lynn Abbott-McCloud

Although many lung cancer patients have recently enjoyed historic therapeutic advances, patients with small cell lung cancer felt left behind. As NSCLC patients organized and built communities and advanced research around biomarkers, an unintended

Full access

EPR24-111: The Clinical Effect of a Community-Based Genetic Testing Program

Danielle Brabender, Emily Siegel, Julie Culver, Jacob Comeaux, Anjali Date, and Amanda Woodworth

Background: Only a subset of individuals meeting NCCN guidelines for genetic screening of hereditary cancers are currently being offered testing. A community-based screening program has the potential to expand access and identify critical

Full access

EPR23-080: Oral Cancer Screening Among the Rural Indians—A Community Based Prospective Study

Tarun Chowdary Gogineni

smoking was reported to be the leading cause of OC. With this, a community based study was conducted to diagnose OC among the smokers. Methods: This is a community based ongoing research, since 01 March 2021. The study protocol was approved by the

Full access

EPR23-079: Cervical Cancer Screening Among the Rural Indians—A Community Based Prospective Study

Tarun Chowdary Gogineni

Methods: This is a community based ongoing research, since 01 March 2021. The study protocol was approved by the institutional ethics committee. The study participants were divided in to two groups. Unmarried, 9 – 26 years were in first group and

Full access

Ensuring Diversity and Inclusion in Clinical Development by Leveraging Community Oncology Centers

Joshua Richter, Stephen J. Noga, and Robert Rifkin

advocacy groups, and others. In this commentary, we propose community oncology center partnerships as one cornerstone of the solution. Racial and ethnic minorities are underrepresented in oncology research despite disproportionate disease burden. Up to 20

Full access

CLO20-045: Initial Experience of Robotic Assisted Colorectal Surgery in a Community Hospital

Adrian Legaspi, Vanitha Vasudevan, Amit Sastry, Jeronimo Garcialopez de Llano, and Marice Ruiz-Conejo

malignancy managed with RACS in a community hospital. Methods: comparative study of the first 57patients treated with RACS for malignant tumors done from 6/17 to 7/19 in a community hospital. The data was then compared to the published literature. Two

Full access

Development and Implementation of a Medical Oncology Quality Improvement Tool for a Regional Community Oncology Network: The Fox Chase Cancer Center Partners Initiative

Margaret A. O'Grady, Elena Gitelson, Ramona F. Swaby, Lori J. Goldstein, Elaine Sein, Patricia Keeley, Bonnie Miller, Tianyu Li, Alan Weinstein, and Steven J. Cohen

Fox Chase Cancer Center Partners (FCCCP) is a community hospital/academic partnership consisting of 25 hospitals in the Delaware Valley. Originally created in 1986, FCCCP promotes quality community cancer care through education, quality assurance, and access to clinical trial research. An important aspect of quality assurance is a yearly medical oncology audit that benchmarks quality indicators and guidelines and provides a roadmap for quality improvement initiatives in the community oncology clinical office setting. Each year, the FCCCP team and the Partner Medical Oncologists build disease site- and stage-specific indicators based on National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology. Concordance with multiple indicators is assessed on 20 charts from each community practice. A report for each FCCCP medical oncology practice summarizes documentation, screening recommendations, new drug use, and research trends in a particular disease site. Descriptive statistics reflect indicators met, number of new cases seen per year, number of disease site cases from tumor registry information, and clinical trial accrual total. Education and documentation tools are provided to physicians and oncology office nursing staff. The FCCCP Clinical Operations Team, consisting of medical oncologists and oncology-certified nurses, has conducted quality audits in medical oncology offices for 7 years using NCCN-derived indicators. Successful audits comprising gastric, colorectal, and breast cancer have been the focus of recent evaluations. For the 2005 stage II/III breast cancer evaluation, mean compliance per parameter was 88%, with 15 of 16 practices achieving mean compliance greater than 80%. A large-scale quality assurance audit in a community cancer partner network is feasible. Recent evaluation of localized breast cancer shows high compliance with guidelines and identifies areas for focused education. Partnership between academic and community oncologists produces a quality review process that is broadly applicable and adaptable to changing medical knowledge.

Full access

NCCN Task Force Report: Specialty Pharmacy

Rowena N. Schwartz, Kirby J. Eng, Deborah A. Frieze, Tracy K. Gosselin, Niesha Griffith, Amy Hatfield Seung, Jennifer M. Hinkel, Philip E. Johnson, Shirley A. Johnson, Edward C. Li, Audrea Hotsko Szabatura, and Michael K. Wong

standard and may include models such as mail-order distribution (the traditional model for specialty pharmacy) or distribution from a community pharmacy. One historic feature of specialty pharmacy is the focus on diseases that are chronic and low

Full access

YIA23-006: BE-EPIC: Behavioral Economic Interventions to Embed Palliative Care in Community Oncology

Ravi B. Parikh, Ramy Sedhom, William J. Ferrell, Katherine Villarin, Kara Berwanger, Bethann Scarborough, Randall Oyer, Pallavi Kumar, Niharika Ganta, Shanthi Sivendran, Jinbo Chen, Kevin G. Volpp, and Justin E. Bekelman

-based criteria to clinicians on (1) PC referrals and completed visits, and (2) quality of life. Methods: This 2-arm pragmatic randomized trial, conducted in a large, rural community oncology practice, randomizes 4 clinician-pods, consisting of approximately 250

Full access

HSR20-109: Using Promotoras in a US-Mexico Hispanic Border Community to Provide Palliative Care

Gabriela Abigail Villanueva

marginalized groups. Our objective is to provide quality palliative care to oncology Hispanic patients along the Mexico-US border by using community health workers (promotoras) to deliver a comprehensive and culturally sensitive educational intervention. We